Review of the Cancer Genome Atlas of 135 primary lung adenocarcinomas revealed only 3 missense mutations and 1 truncating mutation of BMPR2 [14], suggesting BMPR2 could be targeted with small molecules. The gene discussed is BMPR2; the disease is lung adenocarcinoma.